[go: up one dir, main page]

AU2003259074A8 - Gal3 antagonists for the treatment of neuropathic pain - Google Patents

Gal3 antagonists for the treatment of neuropathic pain

Info

Publication number
AU2003259074A8
AU2003259074A8 AU2003259074A AU2003259074A AU2003259074A8 AU 2003259074 A8 AU2003259074 A8 AU 2003259074A8 AU 2003259074 A AU2003259074 A AU 2003259074A AU 2003259074 A AU2003259074 A AU 2003259074A AU 2003259074 A8 AU2003259074 A8 AU 2003259074A8
Authority
AU
Australia
Prior art keywords
treatment
neuropathic pain
gal3
antagonists
gal3 antagonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003259074A
Other versions
AU2003259074A1 (en
Inventor
Thomas Blackburn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lundbeck Research USA Inc
Original Assignee
Synaptic Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synaptic Pharmaceutical Corp filed Critical Synaptic Pharmaceutical Corp
Publication of AU2003259074A1 publication Critical patent/AU2003259074A1/en
Publication of AU2003259074A8 publication Critical patent/AU2003259074A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04M—TELEPHONIC COMMUNICATION
    • H04M3/00—Automatic or semi-automatic exchanges
    • H04M3/22—Arrangements for supervision, monitoring or testing
    • H04M3/2281—Call monitoring, e.g. for law enforcement purposes; Call tracing; Detection or prevention of malicious calls
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Computer Security & Cryptography (AREA)
  • Technology Law (AREA)
  • Signal Processing (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003259074A 2002-08-07 2003-08-07 Gal3 antagonists for the treatment of neuropathic pain Abandoned AU2003259074A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21526702A 2002-08-07 2002-08-07
US10/215,267 2002-08-07
PCT/US2003/024869 WO2004014307A2 (en) 2002-08-07 2003-08-07 Gal3 antagonists for the treatment of neuropathic pain

Publications (2)

Publication Number Publication Date
AU2003259074A1 AU2003259074A1 (en) 2004-02-25
AU2003259074A8 true AU2003259074A8 (en) 2004-02-25

Family

ID=31714268

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003259074A Abandoned AU2003259074A1 (en) 2002-08-07 2003-08-07 Gal3 antagonists for the treatment of neuropathic pain

Country Status (2)

Country Link
AU (1) AU2003259074A1 (en)
WO (1) WO2004014307A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7642281B2 (en) 2002-08-07 2010-01-05 Helicon Therapeutics, Inc. Indolone compounds useful to treat cognitive impairment
GB0323137D0 (en) 2003-10-03 2003-11-05 Chang Lisa C W 2,4,6- Trisubstituted pyrimidines and their different uses
WO2006065872A1 (en) * 2004-12-13 2006-06-22 Neurogen Corporation Piperazinyl-pyridine analogues
SK500262008A3 (en) * 2005-12-09 2009-03-05 Helicon Therapeutics, Inc. Use of indolone compounds for the manufacture of a medicament for the treatment of cognitive impairment
US8277842B1 (en) 2012-01-20 2012-10-02 Dart Neuroscience (Cayman) Ltd. Enteric-coated HT-2157 compositions and methods of their use
CN103006642B (en) * 2013-01-04 2014-10-22 中国药科大学 Application of alkyne methylene indole-2-one derivative
WO2015054317A1 (en) 2013-10-07 2015-04-16 Kadmon Corporation, Llc Rho kinase inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002060392A2 (en) * 2001-01-31 2002-08-08 Synaptic Pharmaceutical Corporation Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods

Also Published As

Publication number Publication date
WO2004014307A2 (en) 2004-02-19
WO2004014307A3 (en) 2004-12-29
AU2003259074A1 (en) 2004-02-25

Similar Documents

Publication Publication Date Title
HUS2200036I1 (en) Use of dihydroimidazolones for the treatment of dogs
IL161041A0 (en) Mch antagonists for the treatment of obesity
AU2003290605A8 (en) Compositions and methods for the diagnosis and treatment of sepsis
AP2005003336A0 (en) Combination for the treatment of ADHD
AU2003290059A8 (en) Use of cd137 antagonists for the treatment of tumors
AU2003279841A8 (en) Uses of human zven antagonists
GB0213869D0 (en) The treatment of pain
AU154012S (en) Monitor
AU2003259074A8 (en) Gal3 antagonists for the treatment of neuropathic pain
AU2003242614A8 (en) Method for the preparation of halogenated benzonitriles
GB0330049D0 (en) The treatment of neuropathic pain conditions
IL164951A0 (en) The treatment of pain with lfendropil
IL175574A0 (en) Biomarkers for the efficacy of somatostatin analogue treatment
AU2003259759A1 (en) Gal3 receptor antagonists for the treatment of affective disorders
GB0201025D0 (en) The treatment of degenerative diseases
AU2003238466A8 (en) Device for the compression of materials
AU2003240174A8 (en) Compositions for the treatment of edematous-firbrosclerotic panniculopathy
GB0216968D0 (en) Monitor
IL172101A0 (en) Use of indazole derivatives for the treatment of neuropathic pain
AU2002366272A8 (en) Edg-receptor agonist for the treatment of hypertension
GB0219706D0 (en) The treatment of neuropathic pain
GB0322015D0 (en) The treatment of neuropathic pain conditions
GB0325957D0 (en) The treatment of pain
GB0213870D0 (en) The treatment of pain conditions
GB0229986D0 (en) Treatment of materials

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase